Hora Maninder 4
4 · NEKTAR THERAPEUTICS · Filed Apr 12, 2018
Insider Transaction Report
Form 4
Hora Maninder
SVP Pharma Dev and Mfg
Transactions
- Exercise/Conversion
Common Stock
2018-04-10$7.21/sh+502$3,619→ 80,763 total - Exercise/Conversion
Stock Option
2018-04-10−502→ 32,500 totalExercise: $7.21From: 2016-02-08Exp: 2020-02-07→ Common Stock (502 underlying) - Sale
Common Stock
2018-04-10$105.67/sh−502$53,046→ 80,261 total
Footnotes (3)
- [F1]This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- [F2]This number includes 6,500 shares held by the reporting person from the Issuer's ESPP plan. The acquisition of these shares under this plan is exempt under Rule 16b-3(c).
- [F3]This transaction was executed in multiple trades at prices ranging from $105.03 to $105.81. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.